<SEC-DOCUMENT>0001140361-21-020736.txt : 20210614
<SEC-HEADER>0001140361-21-020736.hdr.sgml : 20210614
<ACCEPTANCE-DATETIME>20210614092724
ACCESSION NUMBER:		0001140361-21-020736
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210614
FILED AS OF DATE:		20210614
DATE AS OF CHANGE:		20210614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		211013574

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>nt10025526x4_6k.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.5.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: center; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center"><font style="font-size: 14pt;">&#160;FORM 6-K</font></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 under</div>
    <div style="text-align: center;">t<font style="font-weight: bold;">he Securities Exchange Act of 1934</font></div>
    <div><br>
    </div>
    <div style="text-align: center;">For the month ended June, 2021</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ICON plc</div>
    <div style="text-align: center;">(Registrant's name)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">333-08704</div>
    <div style="text-align: center;">&#160;(Commission file number)</div>
    <div><br>
    </div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland</div>
    <div style="text-align: center;">(Address of principal executive offices)</div>
    <div><br>
    </div>
    <div style="text-align: center;">Brendan Brennan, CFO</div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland.</div>
    <div style="text-align: center;">Brendan.Brennan@iconplc.com</div>
    <div style="text-align: center;">00-353-1-291-2000</div>
    <div style="text-align: center;">&#160;(Name, telephone number, email and/or facsimile number and address of Company contact person)</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zed1e85bf83874124930fe8a46cf9c2bb" cellpadding="0" cellspacing="0">

        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Form 20-F __<font style="font-weight: bold;">X</font>___</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>Form 40-F ______</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule12g3-2(b) under the Securities Exchange Act of 1934.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82 <font style="font-weight: bold;">N/A</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <div>On June 14, 2021, ICON plc (&#8220;ICON&#8221;) issued a press release announcing, in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. (&#8220;PRA&#8221;) pursuant to which Indigo Merger Sub, Inc., a wholly owned subsidiary of ICON (&#8220;Merger
      Sub&#8221;), will merge with and into PRA (the &#8220;Merger&#8221;), with PRA surviving the Merger, that Merger Sub intends to offer $500 million aggregate principal amount of Senior Secured Notes due 2026 and $1,515 million aggregate principal amount of Senior
      Secured Notes due 2028 in a private offering (the &#8220;Proposed Offering&#8221;), subject to market and other conditions, in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. A copy of the press release is
      attached hereto as Exhibit 99.1 to this Form 6-K and is incorporated herein by reference.<br>
    </div>
    <div><br>
    </div>
    <div>In connection with the Proposed Offering, ICON disclosed certain information to prospective investors in a preliminary offering memorandum, dated June 14, 2021 (the &#8220;Preliminary Offering Memorandum&#8221;), excerpts of which are furnished herewith, in
      the general form presented in the Preliminary Offering Memorandum, as Exhibit 99.2 to this Form 6-K and are incorporated herein by reference.</div>
    <div><br>
    </div>
    <div>The information disclosed under in this Form 6-K is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing made under the
      Securities Act of 1933, except as expressly set forth by specific reference in such filing.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Cautionary Note Regarding Forward-Looking Statements</div>
    <div><br>
    </div>
    <div>This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
      amended. These forward-looking statements generally include statements regarding the potential transaction between ICON public limited company, a public limited company in Ireland (&#8220;ICON&#8221;) and PRA Health Sciences, Inc., a Delaware corporation
      (&#8220;PRA&#8221;), including any statements regarding the expected timetable for completing the potential transaction, the ability to complete the potential transaction, the expected benefits of the potential transaction (including anticipated synergies,
      projected financial information and future opportunities) and any other statements regarding ICON&#8217;s and PRA&#8217;s future expectations, beliefs, plans, objectives, results of operations, financial condition and cash flows, or future events or performance.
      These statements are often, but not always, made through the use of words or phrases such as &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar expressions. All such forward-looking
      statements are based on current expectations of ICON&#8217;s and PRA&#8217;s management and therefore involve estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from the
      results expressed in the statements. Key factors that could cause actual results to differ materially from those projected in the forward-looking statements include the ability to obtain the requisite ICON and PRA stockholder approvals; uncertainties
      as to the timing to consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; litigation relating to the potential transaction that has been or could be instituted against ICON, PRA or
      their respective directors; the effects of disruption to ICON&#8217;s or PRA&#8217;s respective businesses; restrictions during the pendency of the potential transaction that may impact ICON&#8217;s or PRA&#8217;s ability to pursue certain business opportunities or
      strategic transactions; the effect of this communication on ICON&#8217;s or PRA&#8217;s stock prices; transaction costs; ICON&#8217;s ability to achieve the benefits from the proposed transaction; ICON&#8217;s ability to effectively integrate acquired operations into its
      own operations; the ability of ICON or PRA to retain and hire key personnel; unknown liabilities; and the diversion of management time on transaction-related issues. Other important factors that could cause actual results to differ materially from
      those in the forward-looking statements include the effects of industry, market, economic, political or regulatory conditions outside of ICON&#8217;s or PRA&#8217;s control (including public health crises, such as pandemics and epidemics); risks regarding PRA&#8217;s
      ability to maintain large customer contracts or enter into new contracts; PRA&#8217;s ability to attract suitable investigators and patients for its clinical trials; PRA&#8217;s ability to keep pace with rapid technological change; PRA&#8217;s potential liability if a
      patient is harmed; and the factors set forth under the heading &#8220;Risk Factors&#8221; of ICON&#8217;s Annual Report on Form 20-F and PRA&#8217;s Annual Report on Form 10-K and most recent Quarterly Report on Form 10-Q, and in subsequent filings with the U.S. Securities
      and Exchange Commission (the &#8220;SEC&#8221;). These risks, as well as other risks associated with the potential transaction, are more fully discussed in the joint proxy statement/prospectus filed with the SEC in connection with the proposed transaction. Other
      unpredictable or unknown factors not discussed in this communication could also have material adverse effects on forward-looking statements. Neither ICON nor PRA assumes any obligation to update any forward-looking statements, except as required by
      law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="font-weight: bold;">No Offer or Solicitation</div>
    <div><br>
    </div>
    <div>This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer,
      solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. <br>
    </div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Important Information for Investors and Stockholders</div>
    <div><br>
    </div>
    <div>In connection with the potential transaction, ICON has filed a registration statement on Form F-4 (File No. 333-254891) with the SEC containing a prospectus of ICON that also constitutes a proxy statement of each of ICON and PRA. The registration
      statement, as amended, was declared effective by the SEC on April 27, 2021.&#160; Each of ICON and PRA commenced mailing copies of the definitive joint proxy statement/prospectus to stockholders of ICON and PRA, respectively, on or about April 27, 2021.&#160;&#160;
      ICON and PRA may also file other documents with the SEC regarding the potential transaction.&#160; This communication is not a substitute for the joint proxy statement/prospectus or registration statement or for any other document that ICON or PRA have
      filed or may file with the SEC in connection with the potential transaction. INVESTORS AND SECURITY HOLDERS OF ICON AND PRA ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS
      WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL IMPORTANT INFORMATION. Investors and security holders are able to obtain free copies of the joint proxy statement/prospectus and other
      documents filed with the SEC by ICON or PRA through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by ICON are available free of charge on ICON&#8217;s website at https://www.iconplc.com and copies of
      the documents filed with the SEC by PRA are available free of charge on PRA&#8217;s website at https://www.prahs.com/. Additionally, copies may be obtained by contacting the investor relations departments of ICON or PRA.</div>
    <div><br>
    </div>
    <div>ICON and PRA and certain of their respective directors, certain of their respective executive officers and other members of management and employees may be considered participants in the solicitation of proxies with respect to the potential
      transaction under the rules of the SEC. Information about the directors and executive officers of ICON is set forth in its annual report on Form 20-F, which was filed with the SEC on February 24, 2021. Information about the directors and executive
      officers of PRA is set forth in its Amendment to Annual Report on Form 10-K/A for the fiscal year ended December 31, 2020, which was filed with the SEC on March 30, 2021. These documents can be obtained free of charge from the sources indicated
      above. Additional information regarding the interests of such participants in the solicitation of proxies in respect of the potential transaction are included in the registration statement and joint proxy statement/prospectus and other relevant
      materials filed with the SEC.</div>
    <div><br>
    </div>
    <div>The term &#8220;ICON&#8221; and such terms as &#8220;the company,&#8221; &#8220;our,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;its&#8221; may refer to ICON public limited company, one or more of its consolidated subsidiaries, or to all of them taken as a whole. All of these terms are used for convenience
      only and are not intended as a precise description of any of the separate companies, each of which manages its own affairs.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>E<font style="font-weight: bold;">XHIBIT LIST</font></div>
    <div><br>
    </div>
    <div>
      <table id="z6d544a2634b44c3dbfaeb84a7c5f2e63" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 7%;"><u>Exhibit</u><br>
            </td>
            <td style="width: 3%;">
              <div>&#160;</div>
            </td>
            <td style="width: 90%;">
              <div style="text-align: left;"><u>Description</u></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%;"><a href="nt10025526x4_ex99-1.htm">99.1</a><br>
            </td>
            <td rowspan="1" style="width: 3%;">&#160;</td>
            <td rowspan="1" style="width: 90%;">Press Release, dated June 14, 2021<br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;"><a href="nt10025526x4_ex99-2.htm">99.2</a></td>
            <td style="width: 3%;">
              <div>&#160;</div>
            </td>
            <td style="width: 90%;">
              <div style="text-align: left;">Excerpts from preliminary offering memorandum, dated June 14, 2021</div>
            </td>
          </tr>

      </table>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div><br>
    </div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z35fba48fdcc84ce58c0aee4f6f72f6e6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div style="font-weight: bold;">ICON plc</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle; border-bottom: #000000 2px solid;">
            <div>/s/ Brendan Brennan</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top;">
            <div>Date: June 14, 2021</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>Brendan Brennan</div>
            <div>Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>nt10025526x4_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.5.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div>
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;"><img src="nt10025526x4_graphic01.jpg" height="51" width="189"></div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ICON Announces Private Offering of Senior Secured Notes</div>
    <div><br>
    </div>
    <div style="background-color: #FEFEFE;">
      <div><font style="font-weight: bold;">Dublin, Ireland, June 14, 2021 &#8211; ICON plc (NASDAQ: ICLR)
          (&#8220;ICON&#8221;)</font> announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. (&#8220;PRA&#8221;) pursuant to which Indigo Merger Sub, Inc., a wholly owned subsidiary of ICON (&#8220;Merger Sub&#8221;) will merge with and into PRA (the
        &#8220;Merger&#8221;), with PRA surviving the Merger, that Merger Sub intends to offer $500 million aggregate principal amount of Senior Secured Notes due 2026 and $1,515 million aggregate principal amount of Senior Secured Notes due 2028 (collectively, the
        &#8220;Notes&#8221;) in a private offering (the &#8220;Offering&#8221;), subject to market and other conditions.</div>
      <div><br>
      </div>
      <div>ICON intends to use the proceeds from the Offering, together with cash on hand and borrowings made under a proposed new credit facilities to be entered into
        in connection with the closing of the Merger, to (i) fund the cash consideration payable by ICON for the Merger, (ii) refinance and repay certain existing indebtedness of ICON, its subsidiaries and PRA (the &#8220;Refinancing&#8221;) and (iii) pay fees and
        expenses related to the Merger, the Refinancing and the Offering. Upon the consummation of the Merger, the Notes will be guaranteed on a senior secured basis by ICON and certain of its direct and indirect subsidiaries that will guarantee the new
        credit facilities.</div>
      <div><br>
      </div>
    </div>
    <div>This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the Notes (and the guarantees) or any other securities <font style="color: #000000;">or a solicitation of any vote or approval</font>, nor will there be any sale of the Notes (or any guarantees) or any other securities in any state or other
      jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. The Notes (and the guarantees) will be offered and sold in reliance on
      an exemption from the registration requirements provided by Rule 144A under the Securities Act of 1933 (the &#8220;Securities Act&#8221;) and to non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. None of the Notes or
      related guarantees have been registered under the Securities Act or the securities laws of any state or other jurisdiction, and the Notes (and such guarantees) may not be offered or sold in the United States absent registration or an applicable
      exemption from the registration requirements of the Securities Act and the securities laws of any applicable state or other jurisdiction. There can be no assurance that the proposed offering of Notes will be completed.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Forward-Looking Statements</div>
    <div><br>
    </div>
    <div>This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the
      Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements relating to the Notes and related financing transactions and regarding the potential
      transaction between ICON public limited company, a public limited company in Ireland (&#8220;ICON&#8221;) and PRA Health Sciences, Inc., a Delaware corporation (&#8220;PRA&#8221;), including any statements regarding the expected timetable for completing the potential
      transaction, the ability to complete the potential transaction, the expected benefits of the potential transaction (including anticipated synergies, projected financial information and future opportunities) and any other statements regarding ICON&#8217;s
      and PRA&#8217;s future expectations, beliefs, plans, objectives, results of operations, financial condition and cash flows, or future events or performance. These statements are often, but not always, made through the use of words or phrases such as
      &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar expressions. All such forward-looking statements are based on current expectations of ICON&#8217;s and PRA&#8217;s management and therefore involve
      estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from the results expressed in the statements. Key factors that could cause actual results to differ materially
      from those projected in the forward-looking statements include the ability to obtain the requisite ICON and PRA stockholder approvals; uncertainties as to the timing to consummate the potential transaction; the risk that a condition to closing the
      potential transaction may not be satisfied; potential litigation relating to the potential transaction that could be instituted against ICON, PRA or their respective directors; the effects of disruption to ICON&#8217;s or PRA&#8217;s respective businesses;
      restrictions during the pendency of the potential transaction that may impact ICON&#8217;s or PRA&#8217;s ability to pursue certain business opportunities or strategic transactions; the effect of this communication on ICON&#8217;s or PRA&#8217;s stock prices; transaction
      costs; ICON&#8217;s ability to achieve the benefits from the proposed transaction; ICON&#8217;s ability to effectively integrate acquired operations into its own operations; the ability of ICON or PRA to retain and hire key personnel; unknown liabilities; and
      the diversion of management time on transaction-related issues. Other important factors that could cause actual results to differ materially from those in the forward-looking statements include the effects of industry, market, economic, political or
      regulatory conditions outside of ICON&#8217;s or PRA&#8217;s control (including public health crises, such as pandemics and epidemics); risks regarding PRA&#8217;s ability to maintain large customer contracts or enter into new contracts; PRA&#8217;s ability to attract
      suitable investigators and patients for its clinical trials; PRA&#8217;s ability to keep pace with rapid technological change; PRA&#8217;s potential liability if a patient is harmed; and the factors set forth under the heading &#8220;Risk Factors&#8221; of ICON&#8217;s Annual
      Report on Form 20-F and PRA&#8217;s Annual Report on Form 10-K, and in subsequent filings with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). These risks, as well as other risks associated with the potential transaction, are more fully discussed
      in the joint proxy statement/prospectus to be filed with the SEC in connection with the proposed transaction. Other unpredictable or unknown factors not discussed in this communication could also have material adverse effects on forward-looking
      statements. Neither ICON nor PRA assumes any obligation to update any forward-looking statements, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>
      <div style="color: #000000; font-weight: bold;">Important Information for Investors and Stockholders</div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; color: #000000;">As announced on February 24th, 2021, ICON and PRA Health Sciences (&#8220;PRA&#8221;) have entered into a definitive merger
        agreement. In connection with the potential acquisition transaction, ICON has filed a registration statement on Form F-4 (File No. 333-254891) with the SEC containing a prospectus of ICON that also constitutes a proxy statement of each of ICON and
        PRA. The registration statement, as amended, was declared effective, by the SEC on April 28, 2021.&#160; Each of ICON and PRA commenced mailing copies of the definitive joint proxy statement/prospectus to stockholders of ICON and PRA, respectively, on
        or about April 28, 2021.&#160; ICON and PRA may also file other documents with the SEC regarding the potential transaction. This communication is not a substitute for the joint proxy statement/prospectus or registration statement or for any other
        document that ICON or PRA have filed or may file with the SEC in connection with the potential transaction. INVESTORS AND SECURITY HOLDERS OF ICON AND PRA ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT ARE FILED OR
        WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Investors and security holders are able to obtain free copies of the joint proxy
        statement/prospectus and other documents filed with the SEC by ICON or PRA through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by ICON are available free of charge on ICON&#8217;s website at
        https://www.iconplc.com and copies of the documents filed with the SEC by PRA are available free of charge on PRA&#8217;s website at https://www.prahs.com/. Additionally, copies may be obtained by contacting the investor relations departments of ICON or
        PRA.</div>
    </div>
    <div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <div style="color: #000000;">ICON and PRA and certain of their respective directors, certain of their respective executive officers and other members of management and
        employees may be considered participants in the solicitation of proxies with respect to the potential transaction under the rules of the SEC. Information about the directors and executive officers of ICON is set forth in its annual report on Form
        20-F, which was filed with the SEC on February 24, 2021. Information about the directors and executive officers of PRA is set forth in its Amendment to Annual Report on Form 10-K/A for the fiscal year ended December 31, 2020, which was filed with
        the SEC on March 30, 2021. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the interests of such participants in the solicitation of proxies in respect of the potential transaction
        are included in the registration statement and joint proxy statement/prospectus and other relevant materials filed with the SEC.</div>
    </div>
    <div><br>
    </div>
    <div style="font-weight: bold;">About ICON</div>
    <div><br>
    </div>
    <div>ICON plc is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and
      government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in
      Dublin, Ireland, ICON employed approximately 16,070 employees in 89 locations in 43 countries as at March 31, 2021.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Source: ICON plc</div>
    <div style="text-align: justify;">Contact: Investor Relations +1888 381 7923 or</div>
    <div style="text-align: justify;">Brendan Brennan Chief Financial Officer +353 1 291 2000</div>
    <div style="text-align: justify;">Jonathan Curtain Vice President Corporate Finance and Investor Relations +353 1 291 2000</div>
    <div style="text-align: justify;">All at ICON.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">ICON/ICLR-F</div>
    <div style="font-weight: bold;"> <br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>nt10025526x4_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.5.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <!--PROfilePageNumberReset%LCR%3%%%-->
  <div>
    <div>
      <div style="margin-right: 5.8pt; color: #231F20;">
        <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    </div>
    <div style="color: rgb(35, 31, 32); font-weight: bold; text-align: right;"> Exhibit 99.2<br>
    </div>
    <div style="color: rgb(35, 31, 32); font-weight: bold; text-align: center;">NON-GAAP FINANCIAL MEASURES</div>
    <div><br>
    </div>
    <div style="margin-left: 8.3pt; color: #231F20;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>EBITDA,
      Adjusted EBITDA, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Adjusted Free Cash Flow,&#160; Cash Conversion and Total Pro Forma Net Debt as presented in this offering memorandum with respect to each of ICON and PRA are
      supplemental financial measures that are not required by, or presented in accordance with, generally accepted accounting principles in the United States (&#8216;&#8216;GAAP&#8217;&#8217;). We define (1) EBITDA as net income <font style="font-style: italic;">before </font>depreciation

      and&#160; amortization&#160; expense,&#160; interest expense, net and provision for income taxes and net income attributable to noncontrolling interests; (2) Adjusted EBITDA as EBITDA <font style="font-style: italic;">plus </font>share of equity method
      investments, stock-based compensation expense, certain transaction-related costs and restructuring charges; (3) Pro Forma EBITDA as net income of the combined company <font style="font-style: italic;">before </font>depreciation and amortization
      expense, interest expense, net and provision for income taxes and share of equity method investments; (4) Pro Forma Adjusted EBITDA as Pro Forma&#160; EBITDA <font style="font-style: italic;">plus&#160; </font>share&#160; of equity method investments, stock-based
      compensation expense, certain transaction-related costs and restructuring charges; (5) Pro Forma Further Adjusted EBITDA as Pro Forma Adjusted EBITDA <font style="font-style: italic;">plus </font>certain cost savings and synergies expected to be
      realized as a result of the Merger; (6) Adjusted Free&#160; Cash&#160; Flow&#160; and&#160; Pro&#160; Forma Adjusted Free Cash Flow, as the case may be, as Adjusted EBITDA or Pro Forma Further Adjusted EBITDA, as the case may be, <font style="font-style: italic;">minus </font>capital

      expenditures; (7) Cash Conversion and Pro Forma Cash Conversion, as the case&#160; may be, as Adjusted Free Cash Flow or Pro Forma Adjusted Free Cash Flow, as the case may be, <font style="font-style: italic;">divided by </font>Adjusted EBITDA or Pro
      Forma Further Adjusted EBITDA, as the case may be and (8) Total&#160; Pro Forma Net&#160;&#160; Debt as the principal amount (without adjustment for deferred financing costs or original issue discount) of total debt of the combined company minus cash and cash
      equivalents of the combined company. EBITDA, Adjusted EBITDA, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Adjusted Free Cash Flow, Cash Conversion, Pro Forma Adjusted Free Cash Flow Pro Forma Cash Conversion and
      Pro&#160; Forma Total&#160; Net Debt are commonly used as measures of financial performance or liquidity, and are used solely as performance and liquidity measures. EBITDA, Adjusted EBITDA, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further
      Adjusted EBITDA, Adjusted Free Cash Flow, Cash&#160; Conversion,&#160; Pro&#160; Forma Adjusted Free Cash Flow, Pro Forma Cash Conversion and Pro Forma Total Net Debt should not be considered measures of financial performance or liquidity under GAAP, and the items
      excluded from EBITDA, Adjusted EBITDA, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Adjusted Free Cash Flow, Cash Conversion, Pro Forma Adjusted Free Cash Flow, Pro Forma Cash Conversion and Pro Forma Total Net Debt
      are significant components in understanding and assessing the combined&#160; company&#8217;s financial performance or liquidity. EBITDA, Adjusted EBITDA, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Adjusted Free Cash Flow,
      Cash&#160; Conversion,&#160; Pro&#160; Forma Adjusted Free Cash Flow,&#160; Pro Forma Cash Conversion and Pro Forma Total Net Debt should not be considered&#160; in isolation or as alternatives to such GAAP measures as net income, cash flows&#160; provided&#160; by&#160; or&#160; used&#160; in
      operating, investing or financing activities or other financial statement data presented in the financial statements&#160; of PRA and ICON or the pro forma financial statements of the combined company as indicators of financial performance. Since EBITDA,
      Adjusted EBITDA, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Adjusted Free Cash Flow,&#160; Cash Conversion, Pro Forma Adjusted Free Cash Flow,&#160; &#160;&#160; Pro Forma Cash Conversion and Pro Forma Total&#160; Net Debt are not
      measures determined in accordance with&#160; GAAP and are susceptible to varying calculations, EBITDA, Adjusted EBITDA, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Adjusted Free Cash Flow,&#160; Cash&#160; Conversion,&#160; Pro Forma
      Adjusted Free Cash Flow, Pro Forma Cash Conversion and Pro Forma Total&#160; Net Debt, as presented, may&#160; not be comparable to other similarly titled measures of other companies. Furthermore,&#160; as&#160; presented&#160; in&#160; this offering memorandum we use ICON&#8217;s
      definition for such non-GAAP measures with respect to PRA, and as a result will differ from PRA&#8217;s historical metrics.</div>
    <div style="margin-left: 8.3pt; color: #231F20;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">iii</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">Accordingly, we have provided reconciliations of such non-GAAP measures under &#8216;&#8216;Summary&#8212;Summary ICON Historical Consolidated Financial Data,&#8217;&#8217; &#8216;&#8216;Summary&#8212;Summary PRA Historical
      Consolidated Financial Data&#8217;&#8217; and &#8216;&#8216;Summary&#8212;Summary Unaudited Pro Forma Condensed Combined Financial Information.&#8217;&#8217; You are encouraged to review those reconciliations carefully.</div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;"> <br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">
      <div style="font-family: 'Times New Roman',Times,serif;">EBITDA, Adjusted EBITDA, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Adjusted Free Cash Flow, Cash Conversion, Pro Forma Adjusted Free Cash Flow, Pro Forma
        Cash Conversion and Pro Forma Total Net Debt have limitations as analytical tools, and should not be considered in isolation or as substitutes for analyzing our results as reported under GAAP.</div>
    </div>
    <br>
    <div style="margin-left: 33.05pt; color: rgb(35, 31, 32); font-weight: bold; text-align: center;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION</div>
    <div><br>
    </div>
    <div style="margin-left: 8.3pt; color: #231F20;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>This offering
      memorandum contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
      These forward-looking statements generally include statements regarding ICON, PRA, the Transactions and related to the Notes and related financing transactions, including any statements regarding the expected timetable for completing the potential
      transaction, the ability to complete the potential transaction, the expected benefits of the potential transaction (including anticipated synergies, projected financial information and future opportunities) and any other statements regarding ICON&#8217;s
      and/or PRA&#8217;s future expectations, beliefs, plans, objectives, results of operations, financial condition and cash flows, or future events or performance. These statements are often, but not always, made through the use of words or phrases such as
      &#8216;&#8216;anticipate,&#8217;&#8217; &#8216;&#8216;intend,&#8217;&#8217; &#8216;&#8216;plan,&#8217;&#8217; &#8216;&#8216;believe,&#8217;&#8217; &#8216;&#8216;project,&#8217;&#8217; &#8216;&#8216;estimate,&#8217;&#8217; &#8216;&#8216;expect,&#8217;&#8217; &#8216;&#8216;may,&#8217;&#8217;&#160; &#8216;&#8216;should,&#8217;&#8217; &#8216;&#8216;will&#8217;&#8217; and&#160; similar expressions. All such forward-looking statements are based, as applicable, on current expectations of ICON&#8217;s and
      PRA&#8217;s management and therefore involve estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from the results expressed in the statements. Key factors that could
      cause actual results to differ materially from those projected in the forward-looking statements include the ability to obtain the requisite ICON and PRA stockholder approvals; uncertainties as to the timing to consummate the potential transaction;
      the risk that a condition to closing the potential transaction may not be satisfied; litigation relating to the potential transaction that has been or could be instituted against ICON, PRA or their respective directors; the effects of&#160; disruption&#160;
      to&#160; ICON&#8217;s&#160; or&#160; PRA&#8217;s respective businesses; restrictions during the pendency of the potential transaction that may impact ICON&#8217;s or&#160; PRA&#8217;s&#160; ability to pursue certain business opportunities or strategic transactions; the effect of this communication
      on ICON&#8217;s or PRA&#8217;s stock prices; transaction costs; ICON&#8217;s ability to achieve the benefits from the proposed transaction; ICON&#8217;s ability to effectively integrate acquired operations into its own operations; the ability of ICON or PRA to retain and
      hire key personnel; unknown liabilities; and the diversion of management time on transaction-related issues. Other important factors that could cause actual results to differ materially from those in the forward-looking statements include the effects
      of industry, market,&#160; economic,&#160; political&#160; or&#160; regulatory conditions outside of ICON&#8217;s or PRA&#8217;s control (including public health crises, such as pandemics and epidemics); risks regarding PRA&#8217;s ability to maintain large customer contracts or enter
      into new contracts; PRA&#8217;s ability to&#160; attract suitable investigators and patients for its clinical trials; PRA&#8217;s ability to keep pace with rapid technological change; PRA&#8217;s potential liability if a patient is harmed and the factors set forth under
      the heading &#8216;&#8216;Risk Factors&#8217;&#8217; beginning on page 27.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">iv</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%Num%7%%%-->
    <div><br>
    </div>
    <div style="text-align: center; color: rgb(35, 31, 32); font-weight: bold;">The Transactions</div>
    <div><br>
    </div>
    <div style="margin-left: 8.3pt; color: #231F20; font-weight: bold;">The Merger</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">On February 24, 2021, ICON, US Holdco, Merger Sub and PRA entered&#160; into&#160; the&#160; Merger Agreement, pursuant to which Merger Sub will merge with and into PRA. At the effective time of the
      Merger (the &#8216;&#8216;Effective Time&#8217;&#8217;), the separate existence of Merger Sub will cease, and PRA will&#160; be&#160; the&#160; surviving&#160; corporation&#160; and&#160; a wholly owned subsidiary of ICON and US Holdco. Following the Merger, PRA common stock will be delisted&#160; from
      Nasdaq, deregistered under the Exchange Act and will cease to be publicly traded.</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">In the Merger, each share of PRA common stock (other than certain excluded shares and dissenting shares) will be converted automatically into the right to receive (i) 0.4125 of one
      ICON ordinary share, which number is referred to as the exchange ratio, and (ii) $80.00 in cash, without interest. The exchange ratio is fixed and will not be adjusted for changes in the market price of either ICON ordinary shares or PRA common stock
      prior to completion of the Merger.&#160; No fractional ICON ordinary shares will be issued upon the conversion of shares of&#160; PRA common stock pursuant to the Merger Agreement. Each PRA stockholder that otherwise would have been entitled to receive a
      fraction of a share of ICON ordinary shares will be entitled to receive cash in lieu of a fractional share. At the Effective Time, all excluded shares (other than subsidiary-held shares) will be canceled&#160;&#160; and will cease to exist, and no payment will
      be made in respect of such shares.</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">At the Effective Time, each PRA stock option, whether vested or unvested, that is outstanding as of immediately prior to the Effective Time, will be assumed by ICON and converted into
      an option to purchase a number of ICON ordinary shares equal to the product of (i) the number of shares of PRA common stock subject&#160; &#160; to such PRA stock option immediately prior to the Effective Time and (ii) the equity award conversion ratio (as
      defined below) (rounded down to the nearest whole number of ICON ordinary shares on an award-by-award&#160; basis), with an exercise price equal to the quotient of (x) the exercise price per share of PRA common stock&#160; subject to such PRA stock option and
      (y) the equity award conversion ratio (rounded up to the nearest whole cent), in each case, subject to the same terms and conditions as were applicable to such PRA stock option immediately prior to the Effective Time (including applicable vesting
      conditions). At the Effective Time, each outstanding restricted share of PRA common stock will vest at closing and be converted automatically into the right to receive the Merger consideration for each such share. At the Effective Time, each
      outstanding restricted stock unit award in respect of PRA common stock, whether vested or unvested, will be assumed by ICON and converted into a number of restricted share units with respect to a number of ICON ordinary shares equal to the product of
      (i) the number of such PRA restricted stock units and (ii) the equity award conversion ratio (rounded down to the nearest whole number of ICON restricted share units on an award-by-award basis), subject to the same terms and conditions as were
      applicable to such PRA restricted stock unit award immediately prior to the Effective Time (including applicable vesting conditions).</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">If this offering closes prior to the consummation of the Merger, concurrently with&#160; the&#160; closing&#160; of&#160; this offering, the Escrow Issuer will deposit the gross proceeds from this
      offering of Notes and the Issuer will deposit&#160; (or cause to be deposited) into Escrow Accounts an amount sufficient to pay interest that would accrue on the Notes of each series from the Issue Date (or the last day on which interest was paid on the
      Notes) up to, but excluding, the date that is fifteen calendar days following the Issue Date (the &#8216;&#8216;Initial Accrual Date&#8217;&#8217;). No later than the close of business on the date that is two business days prior to the Initial Accrual Date (the &#8216;&#8216;Initial&#160;&#160;
      Deposit Date&#8217;&#8217;) and every 15 calendar days thereafter (in each case, unless the Release Date or&#160; a&#160; Special Mandatory Redemption has occurred), the Issuer will deposit (or cause to be deposited) to the Escrow Accounts an additional amount of cash
      and/or cash equivalents sufficient to pay the interest that would accrue on the Notes&#160;&#160; of each applicable series to, but excluding, the last day of the next succeeding 15 calendar day period (beginning with the 15 calendar days after the Initial
      Accrual Date) (in each case, as calculated in accordance with the terms of the indenture). The Escrow Release will be subject to the satisfaction of certain conditions, including that the Merger shall have been consummated. If the conditions to the
      Escrow Release have not been satisfied on or prior to the Initial Outside Date (subject to the potential extension of such date pursuant to the terms of the Merger Agreement not beyond the Final Outside Date), or upon the occurrence of certain other
      events, the Notes of each series will be subject to a Special Mandatory Redemption at a price equal to 100% of the initial issue price of the Notes of each applicable series, plus accrued and unpaid interest from the date the Notes are issued up to,
      but not including, the Special Mandatory Redemption Date. The funds deposited into the Escrow Account will be pledged as security for the benefit of the holders of the Notes of the applicable series. See &#8216;&#8216;Description of Notes&#8212;Escrow of Proceeds;
      Special Mandatory Redemption.&#8217;&#8217; </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">7</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <div style="margin-left: 8.3pt; color: #231F20; font-weight: bold;">Financing Transactions</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">In connection with the consummation of the Merger, we intend to enter into the following financing transactions:</div>
    <div><br>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd03da5fe3a004f29a25d8353403daa72" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 48.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 28.3pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">(i) the borrowing of (i) $4,000 million under a new senior secured U.S. dollar denominated term loan facility (the &#8216;&#8216;Term Loan Facility&#8217;&#8217;) and (ii) the entry into a new $300 million senior secured revolving credit
                facility (the &#8216;&#8216;New Revolving Credit Facility&#8217;&#8217; and, together with the Term Loan Facility, the &#8216;&#8216;New Senior Secured Credit Facilities&#8217;&#8217;);</div>
              <div style="color: #231F20;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z76e2931c99094382b03b39822278b5d8" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 48.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 28.25pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">the issuance of $500.0 million aggregate principal amount of 2026 Notes offered hereby; and</div>
              <div style="color: #231F20;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ddd4c419637405a897c10e724df2f36" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 48.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 28.25pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">the issuance of $1,515.0 million aggregate principal amount of 2028 Notes offered hereby.</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;"> <br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">For a more detailed description of the New Senior Secured Credit Facilities, see &#8216;&#8216;Description of Certain Other Indebtedness&#8212;New Senior Secured Credit Facilities.&#8217;&#8217;</div>
    <div><br>
    </div>
    <div style="margin-left: 8.3pt; color: #231F20;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>In addition,
      on the Release Date or, if the Merger is consummated on or prior to the consummation of this offering, the issue date, we intend to repay all amounts outstanding, and terminate all commitments in respect of, (i)(A) ICON Investments Five Unlimited
      Company&#8217;s (&#8216;&#8216;ICON Five&#8217;&#8217;)&#160; 2.32%&#160; Series A Senior&#160; Notes&#160; due December 8, 2023 (the &#8216;&#8216;2023 Series A Notes&#8217;&#8217;) and 2.43% Series B Senior Notes due December 8, 2025 (the &#8216;&#8216;2025 Series B Notes&#8217;&#8217;), both series of which are guaranteed by ICON and ICON
      Global Treasury Unlimited Company, a subsidiary of ICON and (B) our existing multi-currency revolving credit facility (the &#8216;&#8216;Existing Revolving Credit Facility&#8217;&#8217;), dated as of March 12, 2018, by and among ICON, ICON Five, Santander UK PLC
      (&#8216;&#8216;Santander&#8217;&#8217;), as agent, and the lenders party thereto (clauses (i)(A) and (B), collectively, the &#8216;&#8216;Existing ICON Indebtedness&#8217;&#8217;) and (ii)(A) the Credit Agreement, dated October 28, 2019, by and among PRA, PNC Bank, National Association, as
      administrative agent, the lenders party thereto and the other parties thereto and (B) the accounts receivable financing agreement, dated as of March 22, 2016, by and among PRA, PNC Capital Markets LLC, as structuring agent, the lenders party thereto
      and the other parties thereto (clauses (ii)(A) and (B), collectively, the &#8216;&#8216;Existing PRA Indebtedness&#8217;&#8217;).</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">Certain Initial Purchasers or their affiliates may hold a portion of the indebtedness being repaid or refinanced in connection with the Transactions and as a result may receive a
      portion of the net proceeds from this offering. See &#8216;&#8216;Plan of Distribution.&#8217;&#8217;</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">The consummation of the Merger, this offering of Notes, the entry into, and the initial borrowings under, the New Senior Secured Credit Facilities and the refinancing of the Existing
      ICON Indebtedness and the Existing PRA Indebtedness, together with the payment of fees and expenses relating thereto,&#160; are&#160; referred&#160; to&#160; in&#160; this offering memorandum collectively as the &#8216;&#8216;Transactions.&#8217;&#8217;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">8</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="color: rgb(35, 31, 32); font-weight: bold; text-align: center;">Sources and Uses</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">The following table sets forth estimated sources and uses of funds in connection with the Transactions, including the proceeds of the Notes offered hereby, assuming the Transactions
      occurred on March 31, 2021. Amounts shown in the table below are estimated and approximate. Actual amounts may vary from estimated amounts due to several factors, including the amount of available cash and debt as of the closing date of the Merger
      and differences from our estimate of transaction fees and expenses.</div>
    <div><br>
    </div>
    <table id="z08084402d9214d8c9efb7089fdb3625c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" cellpadding="0" cellspacing="0">

        <tr>
          <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div><font style="font-weight: bold; color: rgb(35, 31, 32);">Sources of funds</font><br>
            </div>
          </td>
          <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(35, 31, 32);"> <font style="font-weight: bold;">Amount</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="text-align: center;"><font style="font-weight: bold; color: rgb(35, 31, 32);">Uses&#160; of funds</font><br>
            </div>
          </td>
          <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(35, 31, 32);"> <font style="font-weight: bold;">Amount</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align: top;" valign="bottom">
            <div style="text-align: center; color: rgb(35, 31, 32);">(dollars in millions)</div>
          </td>
          <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td rowspan="1" style="vertical-align: top;" valign="bottom">
            <div style="text-align: center; color: rgb(35, 31, 32);">(dollars in millions)</div>
          </td>
          <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 38%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Cash<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">1,241.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; width: 38%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Equity Purchase Price<br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20;">11,148.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 38%;" valign="bottom">&#160;</td>
          <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; width: 38%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);"><font style="font-style: italic;">Stock Consideration&#160;</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20;">5,773.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 38%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; width: 38%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);"><font style="font-style: italic;">Cash Consideration&#160;</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20;">5,375.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 38%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Term Loan Facility<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup><br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">4,000.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; width: 38%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Existing ICON Indebtedness and Existing PRA Indebtedness </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20;">1,631.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 38%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">ICON Equity<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(c)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">5,773.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; width: 38%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Estimated fees and expenses related to the Transactions<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(d)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20;">250.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 38%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">2026 Notes offered hereby</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20;">500.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; width: 38%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 38%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">2028 Notes offered hereby</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">1,515.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; width: 38%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 38%; padding-bottom: 4px;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Total sources<br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">13,029.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td style="vertical-align: top; width: 38%; padding-bottom: 4px;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Total uses<br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: #231F20;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: #231F20;">13,029.0</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>

    </table>
    <div><u><br>
      </u> </div>
    <u> </u>
    <div><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
    </div>
    <div><u> <br>
      </u></div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zefaa946e0f284513a43a06cebd01a1f0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.3pt;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">Cash is derived from the actual combined cash and equivalents of ICON and PRA as of March 31, 2021. As of March 31, 2021, prior to giving effect to the Transactions, the combined company would have had cash and
                cash equivalents of approximately $1,632.7 million and, after giving effect to the Transactions, would have had approximately $391.7 million of cash and&#160; cash equivalents. As of May 31, 2021, prior to giving effect to the Transactions, the
                combined company would have had cash and cash equivalents of approximately $1,690.0 million. See &#8216;&#8216;Summary&#8212;Summary PRA Historical Financial Data,&#8217;&#8217; &#8216;&#8216;Summary&#8212;Summary ICON Historical Financial Data,&#8217;&#8217; &#8216;&#8216;Use of Proceeds,&#8217;&#8217; &#8216;&#8216;Capitalization&#8217;&#8217;
                and ICON&#8217;s Unaudited Pro Forma Condensed Combined Financial Statements (the &#8216;&#8216;Pro Forma Financial Statements&#8217;&#8217;) incorporated by reference into this offering memorandum from ICON&#8217;s Current Report on Form 6-K filed by ICON on June 14, 2021
                (the &#8216;&#8216;Pro Forma 6-K&#8217;&#8217;) for additional information.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0b6f25668c7740c984f1b379b80ddb0f" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.3pt;">(b)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">See &#8216;&#8216;Summary&#8212;Financing Transactions&#8217;&#8217; and &#8216;&#8216;Description of Certain Other Indebtedness&#8212;New Senior Secured Credit Facilities.&#8217;&#8217;</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z96b6fed85df74d0c96f57025b76a0acc" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.25pt;">(c)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">
                <div style="color: #231F20;">Represents the stock portion of the consideration for the Merger of 0.4125 ordinary shares of ICON for each share of PRA based on a fixed exchange ratio, calculated using the ICON share price as of May 31, 2021.
                  See the Pro Forma 6-K for additional information, including for the number of PRA shares outstanding as of March 31, 2021.</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc3c822f9e30d4120b542f29998a74830" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.25pt;">(d)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">Represents estimated fees and expenses associated with the Transactions, including financing fees, original issue discounts, legal, advisory and professional fees, and other transaction costs such as printing and
                rating agency fees. To the extent any financing fees, original issue discounts and other fees and expenses exceed the estimated amounts, we expect to fund such amounts with cash of the combined company at the closing of the Transactions.</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">9</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
  </div>
  <!--PROfilePageNumberReset%Num%24%%%-->
  <div>
    <div><br>
    </div>
    <div style="margin-left: 20.6pt; color: rgb(35, 31, 32); font-weight: bold; text-align: center;">SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">The following summary unaudited pro forma condensed combined financial&#160; information&#160; for&#160; the&#160; three months ended March 31, 2021, the three months ended March 31, 2020 and the year
      ended December 31, 2020 combine the historical consolidated statements of earnings of ICON and PRA. The summary unaudited pro forma condensed combined statement of earnings for the three months ended March 31, 2021, the three months ended March 31,
      2020 and the year ended December 31, 2020 is presented as if the Merger had occurred on January 1, 2020, the beginning of the earliest period presented. The following table also presents certain other financial data&#160; for the combined company for the
      twelve months ended March 31, 2021, which were derived by adding the pro forma condensed combined financial information for the combined company for the three months ended&#160; March 31, 2021 with the pro forma condensed combined financial information
      for the&#160; fiscal&#160; year&#160; ended December 31, 2020 and then deducting the pro forma condensed combined financial information for the three months ended March 31, 2020. The summary unaudited pro forma financial information and other financial data are
      based on the historical consolidated financial statements of ICON and PRA, and certain assumptions and adjustments. See &#8216;&#8216;Unaudited Pro Forma Condensed Combined Financial Information&#8217;&#8217; for more information. </div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">The summary unaudited pro forma financial information for the Merger has&#160; been&#160; developed&#160; from,&#160; and should be read in conjunction with, the ICON and PRA unaudited interim condensed
      consolidated financial statements contained in the ICON Quarterly Report on Form 6-K and PRA Quarterly Report on Form 10-Q for&#160; &#160;&#160; the three months ended March 31, 2021, respectively, the ICON audited consolidated financial&#160; statements contained in
      the ICON Annual Report on Form 20-F and the PRA audited consolidated financial statements contained in the PRA Annual Report on Form 10-K for the year ended&#160; December&#160; 31,&#160; 2020,&#160; which&#160; is incorporated by reference into this offering memorandum, and
      the more detailed Pro Forma Financial Statements, including the notes thereto, appearing in the Pro Forma 6-K incorporated by reference into this offering memorandum. See &#8216;&#8216;Where You Can Find Additional Information&#8217;&#8217;.</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">The summary unaudited pro forma financial information was prepared using the acquisition method of accounting with ICON treated as the accounting acquirer and therefore, the historical
      basis of ICON&#8217;s assets and liabilities was not affected by the Merger. The summary unaudited pro forma financial information is provided for informational purposes only and is based on available information and assumptions that ICON believes are
      reasonable. It does not purport to represent what our actual consolidated results of operations or the consolidated financial position would have been had the Merger occurred on the dates&#160; indicated,&#160; nor&#160; is&#160; it&#160; necessarily indicative of future
      consolidated results of operations or consolidated financial position. The actual financial position and results of operations will differ, perhaps significantly, from the pro forma amounts reflected herein&#160; due to a variety of factors, including
      access to additional information, changes in the preliminary estimated value&#160;&#160; of acquired assets and liabilities not currently identified and changes in operating results following the date of the pro forma financial information.</div>
    <div></div>
    <div><br>
    </div>
    <table id="z558239418543477c90a6e07da7712459" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" cellpadding="0" cellspacing="0">

        <tr>
          <td rowspan="1" style="vertical-align: top; font-weight: bold; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Year Ended December 31, 2020</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Three Months Ended</div>
            <div><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(35, 31, 32);">March 31,</font> <br>
            </div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Twelve Months Ended</div>
            <div style="font-weight: bold;">March 31,<font style="font-family: 'Times New Roman',Times,serif; color: rgb(35, 31, 32);"> </font></div>
            <div><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(35, 31, 32);">2021</font><br>
            </div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="text-indent: 27.7pt; margin-left: 8.3pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(35, 31, 32);">($&#160; in thousands)</font><br>
            </div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> 2020<br>
          </td>
          <td colspan="1" rowspan="1" style="font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"><font style="font-weight: bold;">2021</font><br>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align: top; font-weight: bold;" valign="bottom">Selected Pro Forma Statements of Operations Data:</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%; background-color: #CCEEFF;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Revenue<br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">5,964,987</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">1,491,059</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">1,791,897</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">6,265,825</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Direct Costs<br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">4,326,680</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">1,103,427</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">1,321,256</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">4,544,509</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%; background-color: #CCEEFF;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Selling, general and administrative</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">1,036,446</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">384,683</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">221,626</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">873,389</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Depreciation and amortization<br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">563,175</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">139,930</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">142,503</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">565,748</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%; background-color: #CCEEFF;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Restructuring<br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">18,089</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">&#8212;</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">&#8212;</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">18,089</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Total costs and expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">5,944,390</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">1,628,040</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">1,685,385</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">6,001,735</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%; background-color: #CCEEFF;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Income/(loss) from operations</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(35, 31, 32);">$</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(35, 31, 32);">20,597</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">(136,981</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">106,512</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">264,090</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Interest income</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">3,048</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">1,809</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">257</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">1,496</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%; background-color: #CCEEFF;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Interest expense</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(308,529</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">(83,729</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(64,929</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(289,729</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Income/(loss) before income taxes expense</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(284,884</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">(218,901</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">41,840</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(24,143</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%; background-color: #CCEEFF;" valign="bottom">
            <div style="margin-left: 2.5pt; color: #231F20;">Income tax (expense)/credit</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">68,841</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">30,276</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(1,090</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">37,475</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%;" valign="bottom">
            <div style="text-indent: -10pt; margin-left: 12.5pt; color: #231F20;">Income before share of earnings from equity method investments</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(216,043</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">(188,625</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">40,750</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(35, 31, 32);">$</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(35, 31, 32);">13,332</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align: top; width: 52%; background-color: #CCEEFF;" valign="bottom">Share of equity method investments</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(366</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">&#8212;</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(274</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">(640</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align: top; width: 52%;" valign="bottom">Net Income/(loss)</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(216,409</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(188,625</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">40,476</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">12,692</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align: top; width: 52%; background-color: #CCEEFF;" valign="bottom">Net income attributable to noncontrolling interest</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(633</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(633</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">&#8212;</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#8212;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align: top; width: 52%;" valign="bottom">Net Income/(loss)</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(217,042</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">$</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">(189,258</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: #231F20; font-weight: bold;">)</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">40,476</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">12,692</div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">24</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 15.2pt; margin-left: 8.3pt; color: #231F20; font-weight: bold;"><br>
    </div>
    <div>
      <table id="z6b6647cf0e9b48379c82bf5f0d572bd6" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" valign="bottom">
              <div style="text-align: center; color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">($ in thousands (except&#160; for</div>
              <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(35, 31, 32);">Pro Forma Cash Conversion and Ratios))</font>&#160;&#160;&#160;&#160;&#160;&#160; <br>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
            <td style="border-bottom: 2px solid rgb(0, 0, 0);" colspan="2" rowspan="1" valign="bottom">
              <div style="text-align: center; color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Twelve</div>
              <div style="text-align: center; color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;"> Months Ended</div>
              <div style="text-align: center; color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;"> March 31, 2021</div>
            </td>
            <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" valign="bottom">
              <div style="text-align: left; color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Other Financial Data:</div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
            <td colspan="2" rowspan="1" valign="bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width: 88%; background-color: #CCEEFF;" valign="bottom">Pro Forma EBITDA<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></td>
            <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</font></td>
            <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">829,198</font></td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width: 88%;" valign="bottom">Pro&#160; Forma Adjusted EBITDA<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></td>
            <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</font></td>
            <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">1,005,735</font></td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width: 88%; background-color: #CCEEFF;" valign="bottom">Pro Forma Further Adjusted EBITDA<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup> <br>
            </td>
            <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</font></td>
            <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">1,155,735</font></td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width: 88%;" valign="bottom">Pro Forma Adjusted Free Cash Flow<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(8)(9)</sup></td>
            <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</font></td>
            <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">1,043,214</font></td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="width: 88%; background-color: #CCEEFF;" valign="bottom">Pro Forma Cash Conversion<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(8)(10)</sup></td>
            <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">90</font></td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">%</font></td>
          </tr>
          <tr>
            <td style="width: 88%;" valign="bottom">Total&#160; Pro Forma Net Debt<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></td>
            <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</font></td>
            <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">5,623,300</font></td>
            <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="background-color: #CCEEFF;" valign="bottom"><font style="color: #231F20;">Ratio of Total Pro Forma Net Debt to Pro Forma Further Adjusted EBITDA</font><sup style="color: #231F20; vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></td>
            <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="text-align: center; background-color: #CCEEFF;" valign="bottom"><font style="color: rgb(35, 31, 32); font-family: 'Times New Roman',Times,serif; font-weight: bold;">4.90 to 1.00</font></td>
            <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
    </div>
    <div><u> <br>
      </u></div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcc6955351965454fa79698469bd7771e" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.3pt;">(1)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Pro Forma Adjusted Free Cash Flow and Pro Forma Cash Conversion as presented in this offering memorandum are supplemental financial
                measures that are not required by, or presented in accordance with, GAAP. We define (1) Pro Forma EBITDA as net income of the combined company <font style="font-style: italic;">before </font>depreciation and amortization expense, interest
                expense, net and provision for income taxes and net income attributable to noncontrolling interests; Pro Forma Adjusted EBITDA as Pro Forma EBITDA <font style="font-style: italic;">plus </font>share of equity method investments,
                stock-based compensation expense, certain transaction-related costs and restructuring charges; (3) Pro Forma Further Adjusted EBITDA as Pro Forma Adjusted EBITDA <font style="font-style: italic;">plus </font>certain cost savings and
                synergies expected to be realized as a result of the Merger; (4) Pro Forma Adjusted Free Cash Flow as Pro Forma Further Adjusted EBITDA <font style="font-style: italic;">minus </font>capital expenditures; (5) Pro Forma Cash Conversion as
                Adjusted Free Cash Flow <font style="font-style: italic;">divided by </font>Pro Forma Further Adjusted EBITDA and (6) Total Pro Forma Net Debt as the principal amount (without adjustment for deferred financing costs or original issue
                discount) of total debt of the combined company minus cash and cash equivalents of the combined company. Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Pro Forma Adjusted Free Cash&#160; Flow, Pro Forma Cash
                Conversion and Total&#160; Pro Forma Net Debt are commonly used as measures of financial performance, and are used solely as performance measures. Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Pro Forma Adjusted
                Free Cash Flow, Pro Forma Cash Conversion and Total Pro Forma Net Debt should not be considered measures of financial performance or liquidity under GAAP, and the items excluded from Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma
                Further Adjusted EBITDA, Pro Forma Adjusted Free Cash Flow, Pro Forma Cash Conversion and Total Pro Forma Net Debt are significant components in understanding and assessing the combined company&#8217;s financial&#160; performance or liquidity.&#160; Pro&#160;
                Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Pro Forma Adjusted Free Cash Flow, Pro Forma Cash Conversion and Total Pro Forma Net Debt should not be considered in isolation or as alternatives to such GAAP
                measures as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in the financial statements of PRA and ICON or the pro forma financial statements of the
                combined company as indicators of financial performance or liquidity. Since Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Pro Forma Adjusted Free Cash Flow, Pro Forma Cash Conversion and Total Pro Forma Net
                Debt are not measures determined in accordance with GAAP and are susceptible to varying calculations, Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Pro Forma Adjusted Free Cash Flow, Pro Forma Cash
                Conversion and Total Pro Forma Net Debt, as presented, may not be comparable to other similarly titled measures of other companies. Pro Forma EBITDA, Pro Forma Adjusted&#160; EBITDA, Pro Forma Further Adjusted EBITDA, Pro Forma Adjusted Free
                Cash Flow, Pro Forma Cash Conversion and Total Pro Forma Net Debt have limitations as analytical tools, and should not be considered in isolation or as substitutes for analyzing our results as reported under GAAP.</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div> </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">25</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="margin-left: 28.3pt; color: #231F20;">The following table sets forth a reconciliation of pro-forma net income to Pro Forma EBITDA, Pro Forma Adjusted EBITDA, Pro Forma Further Adjusted EBITDA, Pro Forma Adjusted Free Cash Flow and Pro Forma
      Cash Conversion:</div>
    <div><br>
    </div>
    <table id="z9d4dd006098148ebb65f8ccbc1b66c31" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" cellpadding="0" cellspacing="0">

        <tr>
          <td colspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">($ in thousands (except&#160; for</div>
            <div><font style="font-weight: bold; color: rgb(35, 31, 32);">Pro Forma Cash Conversion))</font><br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="text-align: center; color: rgb(35, 31, 32); font-weight: bold;">Twelve</div>
            <div style="text-align: center; color: rgb(35, 31, 32); font-weight: bold;">Months Ended</div>
            <div style="text-align: center; color: rgb(35, 31, 32); font-weight: bold;">March 31, 2021</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Net Income/(loss)<br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">12,692</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Depreciation and Amortization</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">565,748</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Interest expense (net)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">288,233</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Provision for income taxes</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">(37,475</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);"><font style="font-weight: bold;">Pro Forma EBITDA</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">829,198</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Share of equity method investments<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div><font style="font-weight: bold; color: rgb(35, 31, 32);">$</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div><font style="font-weight: bold; color: rgb(35, 31, 32);">640</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Stock based compensation expense<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">164,262</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Transaction related costs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div><font style="font-weight: bold; color: rgb(35, 31, 32);">$</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div><font style="font-weight: bold; color: rgb(35, 31, 32);">(6,454</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">
            <div><font style="font-weight: bold; color: rgb(35, 31, 32);">)</font></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Restructuring Charges<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup><br>
            </div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">18,089</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);"><font style="font-weight: bold;">Pro Forma Adjusted EBITDA</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">1,005,735</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Cost savings and synergies<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">150,000</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);"><font style="font-weight: bold;">Pro Forma Further Adjusted EBITDA</font></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">1,155,735</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);">Capital expenditures<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">112,521</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="color: rgb(35, 31, 32);"><font style="font-weight: bold;">Pro Forma Adjusted Free Cash Flow</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">(8)(9)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">$</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">1,043,214</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32);"><font style="font-weight: bold;">Pro Forma Cash Conversion</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">(8)(10)</sup></div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">90</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" nowrap="nowrap" valign="bottom">
            <div style="color: rgb(35, 31, 32); font-weight: bold;">%</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z794876b17cfc4740a221e89dad49e29d" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.3pt;">(2)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">Total Pro Forma Net Debt is equal to (x) the principal amount (without adjustment for deferred financing costs or original issue discount) of $6,015.0 million of total debt of the combined company <font style="font-style: italic;">minus </font>(y) $391.7 million of cash and cash equivalents of the combined company, in each case, as of March 31, 2021 as reflected in the Pro Forma Adjusted column under &#8216;&#8216;Capitalization&#8217;&#8217; after giving
                effect to the cash and cash equivalents used to consummate the Transactions.</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4521a7ae3da748a598a9680f52ba812c" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.3pt;">(3)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">Share of equity method investments include ICON&#8217;s share of gain/loss in respect of its 49% share in the voting interest of Oncacare, which was jointly established with a third party.</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f8c44f17e3d4e6cb0adacecf1c7ce48" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.25pt;">(4)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">Stock based compensation expense reflects non-cash employee compensation expenses.</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d731b0a8f024c5890fe52b8c621dd06" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.3pt;">(5)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #231F20;">Transaction related charges include acquisition (including the Merger) related costs and changes to the fair value of acquisition consideration.</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za3bba4b7e2da46e5bcc7caf2180816ea" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.3pt;">(6)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(35, 31, 32);">Restructuring charges include the cost of resource rationalizations following approval of restructuring plans adopted following a review of resource utilization</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za937bbc048374de5a6896a394bb3b8be" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.3pt;">(7)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(35, 31, 32);">Represents an adjustment to reflect the anticipated annual &#8216;&#8216;run&#160; rate&#8217;&#8217; benefit from certain operational cost synergies expected to be fully realized by the end of the fourth fiscal year following the
                consummation of the Transactions. These assumptions and estimates are inherently uncertain and subject to significant business, operational, economic and competitive uncertainties and contingencies. We cannot assure you that any or all of
                these cost savings and cost synergies will be achieved in the anticipated amounts or within the anticipated timeframes or at all. See &#8216;&#8216;Risk Factors&#8212;Risks Relating to the Merger and the Combined Company after Completion of the Merger&#8212;ICON
                may be unable to realize anticipated cost and tax synergies and expects to incur substantial expenses related to the Merger.&#8217;&#8217;</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3ad9f472e58e4c1eb5a4cba3c72f72b1" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.25pt;">(8)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(35, 31, 32);">Capital expenditures are defined as purchases of and additions to property, plant &amp; equipment, net.</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zed9ca002ad734236b968544438e5bf03" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.25pt;">(9)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(35, 31, 32);">Pro Forma Adjusted Free Cash Flow is defined as Pro Forma Adjusted EBITDA minus capital expenditures.</div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8bcb7a2d7dbb4cf888f1c8c0c73d118b" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 28.3pt; vertical-align: top; align: right;">
              <div style="margin-left: 8.25pt;">(10)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(35, 31, 32);">Pro Forma Cash Conversion is defined as Pro Forma Adjusted Free Cash Flow divided by Pro Forma Adjusted EBITDA.</div>
            </td>
          </tr>

      </table>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">26</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%Num%31%%%-->
    <div style="margin-left: 8.3pt; color: #231F20; font-style: italic; font-weight: bold;">ICON may be unable to realize anticipated cost and tax synergies and expects to incur substantial expenses related to the Merger.</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">ICON expects to generate run rate cost synergies of approximately $150 million and tax savings from the targeted combined effective tax rate decreasing to 14% both to be realized
      within approximately four years after completion of the Merger.</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">ICON&#8217;s ability to achieve such estimated cost and tax synergies in the timeframe described, or at all, is&#160;&#160; subject to various assumptions by ICON&#8217;s management, which may or may not
      prove to be accurate, as well as the incurrence of costs in ICON&#8217;s operations that offset all or a portion of such cost synergies. As a consequence, ICON may not be able to realize all of these cost and tax synergies within the timeframe expected or
      at all. In addition, ICON may incur additional or unexpected costs in order to realize these cost and tax synergies.</div>
    <div><br>
    </div>
    <div style="margin-left: 8.3pt; color: #231F20;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>ICON&#8217;s
      ability to realize tax synergies is also subject to legal uncertainties. For example, see the risk factor entitled &#8216;&#8216;&#8212;There is a risk that, as a result of the Merger, either (1) ICON could be treated as having become a U.S. corporation for U.S.
      federal income tax purposes or (2) ICON and its affiliates could become subject to certain adverse U.S. federal income tax rules.&#8217;&#8217;</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">Failure to achieve the expected cost and tax synergies could significantly reduce the expected benefits associated with the Merger.</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">In addition, ICON has incurred and will incur substantial expenses in connection with completion of the Merger. ICON expects to continue to incur non-recurring costs associated with
      consummating the Merger, combining the operations of the two companies and achieving the desired cost synergies. These fees and costs&#160; have been, and will continue to be, substantial. The substantial majority of nonrecurring expenses will consist of
      transaction costs related to the Merger and include, among others, fees paid to financial, legal and accounting advisors, employee benefit costs and filing fees. Such costs, as well as other unanticipated costs and expenses, could have a material
      adverse effect on the financial condition and operating results of ICON following the completion of the Merger and many of these costs will be borne by ICON even if the Merger is not completed.</div>
    <div><br>
    </div>
    <div style="margin-left: 8.3pt; color: #231F20; font-style: italic; font-weight: bold;">Pending and future tax law changes may result in significant additional taxes to us.</div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">Pending and future tax law changes may result in significant additional taxes to us. For example, the Organization for Economic Cooperation and Development (&#8216;&#8216;OECD&#8217;&#8217;) published a
      &#8216;&#8216;Programme of Work,&#8217;&#8217; which was divided into two pillars. Pillar One focused on the allocation of group profits among taxing jurisdictions&#160; &#160; based on a market-based concept rather than the historical &#8216;&#8216;permanent establishment&#8217;&#8217; concept. Pillar
      Two,&#160; &#160; among other things, introduced a global minimum tax. More recently, on June 5, 2021, the finance ministers of the G7 agreed to (1) reach an equitable solution with respect to Pillar One and (2) a global minimum tax rate of&#160; &#160; &#160; at least 15%
      under Pillar Two. The foregoing proposals (in the event international consensus is achieved and implementing laws are adopted) and other possible future tax changes may have an adverse impact on us.</div>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">31</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
  </div>
  <div>
    <div style="margin-left: 8.3pt; color: #231F20; font-style: italic; font-weight: bold;">There is a risk that, as a result of the Merger, either (1) ICON could be treated as having become a U.S. corporation for U.S. federal income tax purposes or (2)
      ICON and its affiliates could become subject to certain adverse U.S. federal income tax rules. </div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">For U.S. federal income tax purposes, a corporation generally is considered to be a domestic corporation (a &#8216;&#8216;U.S. corporation&#8217;&#8217;), which is subject to U.S. federal income tax on its
      worldwide income, only if such corporation is organized or incorporated under the laws of the United States, any state thereof or the District of Columbia. Accordingly, because ICON is an Irish incorporated entity, it generally would be classified as
      a non-U.S. corporation for U.S. federal income tax purposes. However, the so-called &#8216;&#8216;anti-inversion rules&#8217;&#8217; of Section 7874 of the Code (&#8216;&#8216;Section 7874&#8217;&#8217;) provide an exception to this general rule under which, as a result of&#160; the Merger, either (1)
      ICON might be treated as having become a U.S. corporation for U.S. federal income tax purposes or (2) ICON might remain a non-U.S. corporation for U.S. federal income tax purposes but ICON and&#160;&#160; its affiliates might become subject to certain adverse
      U.S. federal income tax rules. </div>
    <div><br>
    </div>
    <div style="text-indent: 20pt; margin-left: 8.3pt; color: #231F20;">While ICON believes that Section 7874 should not apply to ICON as a result of the Merger, due to the&#160; &#160; factual uncertainty and legal complexity of Section 7874 and the limited
      authority interpreting it, there can be no assurance that ICON&#8217;s view,&#160; if challenged, would be sustained. Moreover, it is possible that a future change in&#160;&#160; law could expand the scope of Section 7874 on a retroactive basis. In this regard, (1) bills
      recently introduced in Congress propose a change to the anti-inversion rules that would, if enacted in its current form, retroactively pose a significant risk that Section 7874 would cause ICON to become a U.S. corporation as a result of the Merger
      (which risk would depend on factors outside of ICON&#8217;s control, including the trading price of ICON common stock on the closing date) and (2) on April 7, 2021, the U.S. Treasury Department released the &#8216;&#8216;Made&#160; &#160;&#160; in America Tax Plan,&#8217;&#8217; which announced
      President Biden&#8217;s proposal to adopt such change, but was silent on whether such change would apply retroactively. More recently, on May 28, 2021, the Treasury Department&#160; released its explanation of the Biden administration&#8217;s tax proposals (commonly
      referred&#160; to&#160; as&#160; the&#160; &#8216;&#8216;Green Book&#8217;&#8217;), which provides that the Biden administration&#8217;s proposed changes to the anti-inversion rules would be effective only for transactions that are completed after the date of enactment. ICON believes that, even if
      the proposed changes were to apply to the Merger (either because the proposals were ultimately enacted with retroactive effect or were enacted prior to the date of the Merger without an exception for transactions occurring pursuant to agreements
      entered into prior to the date of enactment), based on the current facts (including the current trading price of ICON common stock), Section 7874, as amended by the proposed bill in its current form, would not apply,&#160; but due to the factual and legal
      uncertainty with respect to Section 7874, there can be no&#160; assurance that ICON&#8217;s view, if challenged, would be sustained. The application of Section 7874 to ICON could&#160; have a material adverse effect on the financial condition of ICON following the
      completion of the Merger. </div>
    <div><br>
    </div>
    <div style="text-align: center;">32<br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>nt10025526x4_graphic01.jpg
<DESCRIPTION>LOGO
<TEXT>
begin 644 nt10025526x4_graphic01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0C!W8# 2(  A$! Q$!_\0
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MJD6J*:K!AD4O>I-;BT444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI#0 M(33'D
M"#)-5I+^)1]X4[$2FD2R7")U-59+^(?Q"N=U76%1CM>N7O-?89PWZUI&)Q5,
M2COYM4@ ^\*Q[[5(64X85YS>>(YAG#'\ZRSK\SG!8UK%'EXBJI'4ZQ=(ZG!K
ME9G!ILFH/*O)-56D)JSRJFHYCQ35Z&FYHIF5ARTHZTS-./2GL(!]^M&S<*X)
MK,J02E!D46+B=QIUY&KKDUV-IJD(1?F%>-QZE)'R":M1^()E7[QJ&=M*5F>U
M1ZK W\0K0BOXF4?-7A]GXBF,G+'KZUU-CKS%1EJRDCUJ%=)GJ,=PC< U.#FN
M*TW6%:49>NHAOXG PPK)H]*E64B[13%</T-/J3:X4444#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML_2[T74"OG.:T:P/=A-25T+11104%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%)03Q0*XUF ')K!UC5!:+G=5?Q#
MK@T_C=BO/M8\1_; 0'_6M(QN>=B\3R+0U=3\484_/^M<-JFHF[8G=UJO=S-,
M>M4PAS@UO%'AU<2Y"QQDC-.[U(#M3%1U5CBE*X_&^DVYXH5MM.SMYJD2-Z<4
ME!.3FD/2F@8OM1MQ0II2<T[BU C%&.,T$T9XQ4K<!*<%R,TVG!L+BAC$Q0!2
M@T@.*'N(&- .1BAAWH P,U(#@.,4A.UL4H;FF/R^:(C2%9<4PIQ4Q^84S/:F
MBD[$5N3%-G-==I>MFV"_-7)D<TH<CC-)Q.NE7<3V#2O$7GE1N_6NQL[D2H#F
MO!M-U(VS ENE=MI'BL>8D>_K[UA*)ZV%Q5W9GJ -+5&QN1/$K9ZBKN:R:/8C
M)25Q:***104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 444F:74 ) %9>HWH@B9L]*BUG4Q90,V<8KSS4_%0G1D#]?
M>M(QN<.*Q"C'0T-1\3[=PW_K7%:SJYO"1NJA>W;2,>>M9X!+9-="@>%5Q3D,
M\LF0FI@N>*=C I%.#5['!*?,&,<4O3BE/)S32<FC<S;N+TI&%!.:">*=@#9C
MFC%.+?+BFYH6Q08I*7-)3$*JYHQS0C8H!YJ 88YQ1CFC/S4[WJDQ#3Q24I.3
M0!F@.@X+1C%&Z@\T=!">],9<T_H,4"JZ%IV*^TK*#Z5TNFZJ;8+\W2N?8<T9
M/K421T4Z[B>J:3XEW[5W?K7;:??"= <UX+87A@<'-=GIGBD0A07_ %K&4#U<
M-C'S*YZV"#2UC:+J0OK8/NS6P#Q6#5CW(34E="T444BPHHHH **** "BBB@
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MTZ;#@9KU;PMK*O$@=N:YY1/?PF*OH=\*6H(9UE4$&IZR9Z\=@HHHI#"BBB@
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M6XSBO7M-NUGMD.X'BN>2/HL)B.=6-&BD'2EK,]$**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2U'*P5&/M0)NQ!=SK'$Q
MSVKR+Q5KY>Z> -Q73^(]>^S[U#5Y5J,QNKQI<]:VA$\/'8G5I%:1BTF:<.M
M3(S1WKH2T/!E*['.,"F@XI_WA4?>JZDBYYS1GG-"C)H88H>X 3GFEZTVG=*E
MB8=:0FEZ4A'&:0!GBC-&.,T8JD-*X TIXH H^]39(F<49H H R<4F,,\YHS2
MD<XI,<T; !.:,T$4$8HV 2ESQ1CBC'%- )3@<"D XH XH07$-*#BC% HN.P9
MYHSS0!DXH(^;%%]0L!-)FE(YH(Q1U%<,YIM.(Q2LORYI-Z#0F[Y<4@-+CC-
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M(YQ2$<T7T 04I;-!&*2D,4<\4O?%'09H]ZE[DC3Q0#3L9&:0#BFKE)AF@'%
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M$'K2DYHQS01@T;#N)2YH(H(Q1YB#/% /:EV_+F@# S1TN# \<4@.*7J,TF*
M0E*#BC% '-,>P$Y-)2XYHQS3%<"<TE*1S2D4 &ZDW9IVSBFD8J$ =::3CBGC
MIFDVYYIMEQD.MIC;2JP/0UZ=X0UTW&U"W2O+67(K8\.WYLI^O>L91.["UG!G
MT#!('C!!J:N5\/:L+I54M74@Y%<[5CZBC44XW0M%%%(U"BBB@ HHHH ****
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M<!Q/.:0GFDQS1CFA@*3FFT[&*0BD I/&*,\8IM.V\9IA8 >U+TI .]*>:!"
MXH!I,9H- Q=V#FE/*YINW(IX'R;:+E+8C49.:?D^8K#L:0#:,4 \&DP4FF=[
MX5USRF5"U>K6,XGMU?/6OG;3KAK:X5LXYKV;PQJHGMHTW=JYYQ/HLOQ&G*SK
M:*13D4M8GM!1110 4444 %%%% !1110 4444 %%%% "&LC7+\6=L6SCBM.9]
MB%O2O./&6L!XFC#=*J*.;$55"+.2\0ZS]JE90U<RJ_-N-$I:2X))J3':NJ*T
M/E,35<I#6;G-+G>*:RXHCXJD<SV#O3RWRXII'-&*8"4\'"XIF**-P%!H!Q1B
MC&:! #S2@\YI,4G2GU <3SFD)YI*",4F [K2$T*:"*0!GBC/&*,48[TP 'BD
MI<=Z3&:-@'*<4F>: * ,FFP$S\U.]Z:1@TX?=Q4V!B$\T$YI,<TN,4 !-+N^
M7%-(HQQ1U 7-*&PN*3'&:,4QW &C-&,T8H!:!F@'FC%)36X"D\YH)YI*2DT(
M>S9I">*;BG$8%):,8X<BHR<-@4Y305YW535QP=F=;X:UO[&RQEJ]:T:^%W"#
MG/%?/$$C)<JP/ ->J^$-8 14+5SU(GT& Q"3LST<TM11/YB!O6I:P/;3N%%%
M%(84444 %%%% !1110 4444 %%%% "&N9\0ZL+-&7=BMZ[G$$)8FO)?&>J^;
M.RJW>M(1NSBQ=94X&%KFIF]E;#=ZPB-QII8[R2>M2 8&:Z5H?+5IML,_+BF4
MI]:2K3,!<\8IO>G!>,TE*P@SBDQWH(S3@.,4V5?0 :,\T8YQ1CG%%R0)R:7K
M2$8H6D#!C1GB@BC'%) &:7/%)BDJT.X4H.*,9HQ4B#/-&><TF*7%&X!GF@G)
MI,=J7%&X 3F@G(I,8I<4 +N^7%)GC%)2X[T>0P!XHS1CBC&:>PD&: <&@"C'
M-#'<,\T9YI.^*,=J5Q"DY-!-)C%&*+A8>KYXH;DXIJC;S1GG-)@UJ*3@8I5/
MRXII'>@#BFEH F['%+&2C9I-N32GI0UH:*5CL/#FN_9I5!;OZUZYI=V+JT63
M.<BOG2W=HY@03UKV#PAJP>U2$MS7/4B>]E^(]WE9W8.:6F(>*?6#/;B[H***
M*!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(QPN:6JM[.(8&8
MGI0B9.RN8FOZHMO ZYQQ7C.LWC7-R_S9YKJ?%^K^8[*C5P6\N[$]ZZ8(^;QN
M(NP;I3A]W%-QS3AUK8\F;N+T%-I6ZTG>A;$H7&*<AH(R*93Z AW\5)GYJ2CO
M4L!QZT$\TVBGN ]CP*0GBD-)3?8!V?EHSQ2=J2AA8<#Q0*;2XS2Z!853S03\
MU-Z44;#%'WJ5S3:*%N =Z<3Q3:*.H@I^?DQ3,44/48X'Y:13Q24#K2$.'% X
M-!H/2@09YI/XJ2EI[CL*>M(QYHI*;"PI/%*3\M-HI!8=GY:,\4G:DIL+#@>*
M :;24MM L/0\T..]-J0\I2:&1XXS71^'=1-M.F6XS7/=J6&5HI 0<5+V-J%1
MQD?0FC:@MY N#GBM>O,O!.K@*$=J]*B??&&'>N::LSZ_#5%.%Q]%%%0= 444
M4 %%%% !1110 4444 %(>!2U1U"^2TA+,>U I226IS?BG5EB@>,-S7CFI7#3
MW1.<\UTGBG5C<7;[6XKDSEFR:Z(*Q\QCZ_-,<N M(AQFD:D%:GE7 ]:5>M)B
MBJ3T 7^*AJ2BFM!!2TF,44O,8XGB@=*;2KUI=1"]!2"E:DIK4:$I5ZTF**;$
M/[YIO\5.[4REN)#B>:1C244;CL/ZBD/2A:0]:'V$.S\F*911BC8H53Q0#3:6
MD*PH/-.[YIE//W:>PF-_BI2>:;10ACB:#TIM%-(+!3\_+3,4<TO,8[/RTBGB
MDQQ0*3W%844AZT4E [$JD8I,_/3**=M00]^:8!3ATYI1P*.@KC7/(Q79^%-7
M^SRJK-7%DU+:W#PS @XYJ)+0[,+4<9'T5IUV+F ,#UJ_7#>$-5$EJB%N:[=3
MD9KEDK,^IPU7GB.HHHJ3I"BBB@ HHHH **** "BBB@ I">*6H9Y!'&S'M30I
M.RN8^NZFMG P)QD5XSKE^;FZ?YL@FNL\<:MYF4C;I7G)=GD))KHA'0^=QV(N
M[#U&#FC/ST'I3.]:I'BMW8]SFF=Z4TW%5(!YY%!Z8H6D(YJ20'2E[4@H-5L:
M"CI0.*0=:5J&9@#S2'K2447& ZTYJ;THH2Z@'>G'I3<8HH2Z@.)^6C/RTVBD
M%AV>*%I,4G>@+#AQ2J>:1NE(*>X(&ZT#K1UI.E'D,<>M(3244-"L./2@_=IM
M%#06'Y^3%(#\M-HJ1L532BFBBFMA6%!YH/6DHZT+0 HHQ2XJD,3O4AY%1T]/
M>ID SI3R<QXIK#FA:+@- Q6]H&H&WN$!;O6&U$3LDRD'H:B1M1J.,KGT#H>H
M+<P( <\5N5Y9X0UL1[5=J]-MIA-$''>N::LSZS"55.!-1114'6%%%% !1110
M 4444 %%%% !2&EJM>7"V\1=C0)NR.?\2ZJMO;NF<&O&=7NC<W);.>:ZGQAJ
MQFN&5&XKA\E\DUUT4?.9C6O*R C=BGM]T"DC&,YH[U;/(DP[8I,4HZT'K3B0
MMQ0P"XIE(V<TM4BF.6D!YI*3'-2]R1_?-)GYJ7M3*D$2.<TSO11BJ\ACCTHS
MQ2&C%,5A<\4VBC%%P0J]*4&FT4M@L*#S2YYIM%&P6%/WJ4GFFT4(+#F-!/%-
MHH06"G9^6FXHH\P'9XI%-)CB@=:3W"P\<4T'FE;I3<&AL2'?Q9I"?FI?X:90
M-#FZT&D%!%#&MA['Y:CI:,4= '#I2]!BF+UIQZT[DCEX%,;K2FAN11<=Q!P:
MZ?POJAMKQ<MQ7+4^WF:*8%364E<Z\-4<9(^B--U!;J($'-:@Z5YKX0U@%$C9
MN37H\;;D!]JPE&Q]5AJO/$?1114'2%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 A.!7,>)M26"TD7=@XK?NIUBC))Q7DGC35F:Y9$;@UK3C=G#C
M*O+&QQ^I7;W%PV3GFJ@IWWB2:;T-;H^4JSYI$AQMIE*#FD(YJTR+#^HIE*O6
MANM/8D<G2D'6FYQ1F@8H^]2_Q4VBDA6%/6E--HH06'-TH/2FT4!8=_#0/NTV
MB@+!3UQ3*1B15,:''K0!S2"G=J3"]A#24O:E7I1<&-HI:2G<!Q^[3:**0D.'
MW:!P*0=:#4]0%6@=::**JUD%A?XJ=4?>G$_+21:#O2M3!3QTHEH2]P;I0>E-
MHH0K#OX:!]VFT4!8<.E"TVBAA84]:%-)10P'?Q4C=:3-!Y-#6@+1FSH>H-;W
M<8!P,U[CH]XL]G'@\XKYWBD,5PA]#7K/@[5@R*CM6%6)[^6U[+E9Z'13(W#J
M&'0T^N<]]!1110 4444 %%%% !1110 QVPI-<%XZU7RK(K&W.*[*_N%@@<DX
MXKQCQ5J)N+F1,Y%:PC<\S'5^2-CEWN7G<EC3OX:@"X:I5-="1\S5DY,4=*%H
M:FTS(<.M(/O4E%-A8=_%0?O4VBA@/>F4N<TE'08X_=H_AIM%(5AZXVTE-!HI
MK88Y:!UI!3CTILEB#[U(W6DHZT)6'8.].-,I<TD]0L//2@]*92YXJD%A?X:4
M=*9S1FD%@I5I*,XI,!PZT=Z;2]Z?4+"_Q4'K24E'4+"FDI:2GL,>>E(?NT+2
M-UJ62.'W*0=*:I-*:D; 4&@4'I5[%= %+WIM%%Q=!QZT,:!TIM3%ZB&M3CPH
M-%!Z4Y%QE8ZGPGJI@O$5FPM>T:?=I<PAE.>*^;HKE[:0,M>Q>!=5\^Q4.W.*
MYIH]W+L1K9G>44T'(!%.K$]U.X4444#"BBB@ HHHH **** "L37K];>SD&><
M5K32"-"2:\R\;ZOARB-P:N"NSCQ=90@SAM5OFN;N0,<C-9H'-)*Y:0MZFG?P
MUU+8^4JU.9B \TN.:;3^U5L8,:W6@TE+32&MA6Z4I^Y3#1DXJ>H(7M1VI*6F
MAW%'2@4VE%,FPHZTG\5)1286%;K0.M)0*=P'-3:4TE.X(>>E,HS123!(D&-M
M1TN:2@8Y:!UI!24,5AP^]0_6FYH/-);C%'6G-TI@I35(0E./2FTM"8Q?X:!]
MVFT9J16'+TH%-I1306 ]:%ZTE%/R =WH/6FT4@L.-!.!3<T&D]@L//*4WM29
M.**2*#K3E&!FD'6E;BJ:)OJ3V-_);W<>#@;J]T\-7ZW&GQ GG%?/^,2*P[&O
M3/!6K8=8V;@5C4B>SE]>TK'JM%10R"2,,#4M<I](G=7"BBB@84444 %%%% !
M1110 A.!7*>+M26&P8*W.*Z2ZF6&)B3CBO(O&.JF21XPW%7"-V<F+JJ$&<=>
MW3W,Y+'/-0#@T+\RY--[UU+1'R56;E(D;VI&Z4#D4AZTT8]1W:FYXH[4E5LA
MK0<.13:4=:&I)V%U!:4=:04F:=M L._BI&ZTE'6DM %'6E--HS3 <W2EXV4P
MYHR<5/4:'?PTJ_=IE+GBG:XD*.AH7K3:*&%APZTG\5)10PL./6ANM-HH"PXT
M-TIM%'0+#OX:;113Z AZ_<I%[TF:2IL-CE/-.Q40ZU(3\M(EH3/S4C#FDIW5
M:8QHZT]Z92DU2748K=*3M24HZT@0E.'W::>M*.M#$Q1TH4T-TI@I!:X[O35'
MSYHI:$BXRL;7A_4'@U6,9^7->Y:9>+<6Z%3GBOG>&0PRB0=17J_@C5_-@"NW
M-954>WE]>VAZ'13(W#J"*?7,>^G=!1110,**** "BBB@ HHHH **** "BBB@
M HHHH *0]*6HIW"(2::%)V5SF/$^H_9[5\-S7CFI7AO+@L3GFNQ\::F?->,-
M7GP8DDUT05D?,X^NY2T'L,4C#BE^]2KS5H\GJ(*<1\N:83@TN[BK6HV Z4O4
M4W-&:9-A*5>:2@'%# =CFDQ\U&:,\YI,!2.:0BC-&<T,!2.*".*3-&:.@"X^
M6C'%)GM1FCH HZ4@&:,T@-*X!T-&>*5A1CB@+@.N*5CBF@\T$YH 4=:<PX%-
M44,W:G?4=Q2.*7'RYIF>*=NXQ0M1( .*5>0:;GB@' I/<$*!0!S29HS5 (>M
M*/2E(XS3120TQ<<TIXI":0FG('N.(XH(XI,T9I=!"X^6C'%)GM1FCH H'% %
M)G%&:.@ .M+CFFYQ2YH0 >M '-(:>HXS0,9*,,#6YH>JM:S( <<UAO\ ,:="
MWER*?0U$M3>C4<)*Q]#Z)=K<6$;;LDBM6O-_!>L>:4A+=*]&1LC(KEDK,^OP
M]13@F.HHHJ3<**** "BBB@ I&.!FEJK?3"*TD;/04";LCDO&6JBW@(5N<5X_
M?W)GG9B>M=#XIUAKFXDCW=#7+'YN:Z81T/F,PK<TK(<J_)FDZ4Y#VIC\-BM5
MN>7N/'(H I <"C-/H38 .:7'--SBES0@#'S4I'--SSFES0@ BE(XI,YHS0MP
M%(XHQ\M)G-&>*+ +CY: *3/%&<4 **4<TW- -5U%8#UH7K0>M .#04*XYI.]
M!.:*AZ#0YA@4WM2DYIIH3 ?CY,TREW<8IM"$2*,K3.]*&P*2A .09-(?O4@.
M*7/.:$ #[U*XP:;GFE)S1U 3O3V'%1TXMD4[Z@ XI2.,TVESQ3W$Q0.*!R*0
M'M2GBDUJ(1:4<F@\"F@\TABXYH[T9I,\TV/H./!I&I>HS32<TD)!3B.*0"@F
MFU<=A#&&6NM\):F;6XCBS@5R>>,5/971M[I6!QBLI(Z<-4Y)'T58SB:%2#GB
MKE<;X.U/[5;C+=J[$'(KGDM3ZS#3YX)BT445)T!1110 4444 %%%-=@JY- F
M[&)XAOA;6,AW8(%>):OJ+7EPV3G!KN?&VK%)'A#=:\S<Y=CZFNB"/F\PKWDT
M-QDTX>E(*!UK=;'D=1:4'G%)FDSS0Q/8<1S0:4<C--)IW)%(XH(XH'-(3VI
M':E_AIN:7-'0I@!2@4F<49H$*HRU&/FQ2 X-&><TA] _BH(YI,\T[J,T7$!I
M6& *83S2ELBBXT':G8^3-,SQ2[N,4#8E*O(IM*#3)8X"D[T9H[T^HUN '-'\
M5&>:3/-)B%(YI2*.HS32>:5P%(XI3]V@<TA/:BX!VI*,T52V&QP'% %)FC-
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M(?NT <4[@F-I\,K0W,9!QS3>],?J".U)HTIRL[GM_A'4UN+6./=R!78"O%_
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M3O/M&FJQ.3BO!W^4 BO6? MZ/L:(6YKFJH]G+:UI6/1**13E12US'T@4444
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M#SFC/-!&#0!DT[:!80GFG=::1@XIPXJ 8A-&>*"*,52 ,\8H!XHQQFC'%'F
M \4 XH S1C- !FC/.:,9HQ1N $TE+CG%!&#1N,#24I%&*?D%Q2V5Q312XXH
MI(%J+G Q38G\NZ1_0TIZTQER,TF7!VD>R^!M2^U1!<]!7;RMB)C[5XUX O\
M[/-M)ZFO4KN\"V)?/5:Y9+WCZC"5E[$\P\9ZEYEQ)#GI7#+P:UO$<YEU:0Y[
MUEA<UM%61X&-GS5 8Y-)2D8-%;(XP)S1GBC&*2@0N>,4 \4F*7'%3U"P \4
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MT+;I"WK74^-;@SW!&>]<JJX%;P1X6-J\TB0MD8II/&*;WIVWC-7T// 'B@'
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MFYZBN9K4^IP=9.F>=>.-4S.\&:\^3@&M?Q1=&YU9FSGFLGM6\59'A8N?-48
MXH!YHQFD YJSA',.](#2]1BF]*I,$*3S03DTE+BAH+ 303F@C%&*0#L_+BF4
MN.*,4WHAK4=$-[!?6O6?A];^5!TKRFS&;I1[U[/X,CVVX^E<\WH>IED?WAV
MZ4M%%<Y]2%%%% !1110 UQE"/:O./&6E;XW?;7I-8>OV8N+4C&>*J+L<F+I\
M],\ EC\J792;L<5IZY:_9[]ACO62PR<UTPU/DJD;3L+2@XHQFC%:LQ#/-&><
MT8HQS2W ,\T$Y-&.<48HW ":"<T$8HQ0 9XIF><4_'%,Q\U-=AH>I[4K' I
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M_D.'ZURZ]*ZZ6Q\=C_XS'J<4*?FIE%:-'&*W6A>M)UH/%5T <Q^;-(QI*#4
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M(E10 ,5*M%+6)[R6H4444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&*Y&:]CTVS2"!,+@XK&;L>W@,/?5ER&%448%34@Z4M8,]^*LK!1112&%%%%
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M*;GM2YHZ *HXH%-S2YHZ  ZTN.:;G%&:$ O\5*>M-SWI<T(!6H(XIN<TN:$
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M84W-&<T .(XH/ I,TF:.@6'=11CBFY[49HZ!8<M IN<4N:  =:7'S4W-+FA
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M(YHSS1GFA@!%!&*"<T$YH ,<48XS1GBC/&*.@:@!QF@#BC/&*,T=  #- '-
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M'.*=GFDS\U# ,4$8I2>:0F@ Q1CC-*3Q03Q1T 3'&:,4N?EHSQ1T 0#-&,T
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M_P ?B9_O5,T=.%^,]YT+_D'1?2M:LK0_^0?%]*U:Y);GU]#X HHHJ38****
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M:4#+8J4PZC>]+G-*1\V*0CFGL%Q,YHS2D4$8HV$)FC-+CBC'% !FDS2@<9H
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MC-Y'_O5,F=&&_B(]XT(_\2Z+Z5K5DZ%_R#HOI6M7)+<^PH? %%%%2;!1110
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MQ\=J\;\)6WVJ_P!N,X->Z:5#Y%FJ>@KFJ,^DRN":N7J***Q/:"BBB@ HHHH
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MA;_CU7Z5X=IP_P")C']:]Q\+?\>J_2LJFQ[65_Q#I:***YSZ0**** "BBB@
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M=:#S15,!QZT-3<T9S2$./2@_=I,TF:.@#L?+1CBFY[49HZ!8<M IN<4N:.@
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M14FP4444 %(>AI:0]#0!X7\0O^0V?K7+@?+74?$+_D.'ZURX/%=L/A/CL?\
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M, Q01BE)YI":& 8HQCFE)XI">*.@!CC-&.,TN>,49XHZ )C(J_I(S>1_[U4
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MAUI/XJ&%Q**5NM ZU70!,4].*0T,>*EK0+C?X\TIZT=J0T^A;88HIPZ4AH1
MUAFCM3A0:9702C%*O6E_BJ42-HQ2GK2FA -HQ3FH[4(+C<48IW\- ^[0%QN*
M*<.E"T/<+C<44X=:3^*AA<3%%._BI#UH8"8HIQH:@+C<48IW\-'\-'0+C<4H
M'-*.E Z4= %(R*93T/)IIZT1&)70^$(R=9B/O7.FNN\&QYU"-O>IGJCKP?\
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M\5\\HQ3YEZYKU7P'JF+=8W;DUO..AXN#K6J6/4**9&VY ?44^N8^@3N%%%%
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MBC'&: T#/&*,XHQQFC'% !F@'% &: * #-&><T8YHQS1N 9YS1G-&.<48HW
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M:">:3%%%@L*3F@GBDQ1B@ IP/&*3'>@#G-%P8IX&*0&E/--H *5>#28S0:;
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M%O\ CU7Z5E5V/:RO^(=+1117,?2!1110 4444 (:X;XD?\@8_2NY-<-\2/\
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MPOXA?\AL_6N8'W:Z?XA?\AS\:Y89Q7;!^Z?'8_\ C,<M(>M%)5[(XA5ZTO\
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M#HOI6M7++<^PH? %%%%2;!1110 4AZ&EI#T- 'A?Q"_Y#A^M<RGW*Z;XA?\
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M&YUX.JX31] Q2"1 14M8^A70N+0-GM6N*Y6K'UU.7,KBT444BPHHHH ****
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MT_Q"_P"0X?K7,*<+79#X3X['?QF(!0!DXH!I5.#5LXD)CG%&.<49^;-&>:$
M$8I*5C24V"%(H(XI2:0GBET ,<9HQQ1GC%&>*.@ !F@#- .!0#1T  ,FC'-
M.#1GFA &.<48YHSSF@GFA !&*,4$YH)XH0 1Q1CC-!/%&>,4 &.,T 9HSQ0#
M@4=0 #- &30#0#@T, QS1CG%&>:,\YH8!CF@C%!/-!.:& 8H(XH)H)XHZ!J&
M.,T8XS1GC%&>*.@"A<BF8^<'TIZM@4P]#2*3LST?X>WOF70CSTKU<=*\/^'D
MOEZF<GO7MD#[XP:YJBU/J\ME>E8EHHHK(]$**** "BBB@!#7">,](^UJTH7I
M7=FL[581+92#'454=SGQ$.:#3/G>ZB\N=EQT-- R*V?$=F;2Z=L8R:Q$?-=,
M3Y/$0<9-#_:FX^;%&>:,_-FM&<J!EP<4O04K<G--)S2&Q"**7M2520,7'&:,
M<4N>*,\4" +D4VGJV!3#0F,4#-&.:%-&>:8@QS01S2YYS36/.:38(4C%!&!3
M"^:4OD5+92BQV.,TN.*C$F>*4/VIIV#E8ZE R*;GM3P<"G<&AAZT[J*::5>*
M31+#'-&.<49YHSSFA@&*",4$\T$YH8!B@CB@GB@GBCH&H8XS1CC-&>,49XHZ
M  &: ,T XH!HZ  &31CF@'!HSS0@#'.*,49YS03S0@ C%&*"<T$\4+< QQFE
MV_+FD)XIV?EQ28T,I0,TE.!XJN@F(!F@#)Q0#0IP:3!"[><4QQSMJ3/S9IAY
M?-)E1.N\(3>5<1KGJ:]JM3FW0^U>!:!<[-3B7/>O>-/?=:1G_9KFJ(^DRJ7N
MENBBBLCV HHHH **** "N6\86GGZ<PQVKJ:S]6M_/M2N,\5479F&(ASTVCYX
MO8OL]P4]Z@K;\4VAM]1;CO6&IS76GH?(UJ;C*P[%#+@9H)I6.13,&,I^WC--
MI^?EQ3$,I124H--L$ %+UXI <4 \TF)ACG%)CG%.[YH[YI7 :1B@4X\T@ZTX
M@@QLYH/(S3F^<4UCA<4,IZCHH_,<+7JG@G3,0*^*\]T&T-S>*N,YKV[P]9?9
M+0*1VKGJ2/<RVA=W9L(N% I]%%8'OI6"BBB@84444 %(YPA/M2U',<0N?04"
M>QYIX^N]ULR9KRU!QFNO\8W_ )M[)#GH:Y)>%Q79#8^2QL[S:' =Z<>::#Q0
M#5GG@!FC'- - /-##4,<T8YQ1GFC/.:& 8H(Q03S03F@ QQ1CC-*3Q2$\4=
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MC%.S\M ^[0 F*3&:<#Q0IH>X#<48IP/-)_%0P#%)BG9^:D/6A@&*3&*<:&H
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M@-Q1CM3AUI/XJ& 8I,4[/S4AZT, Q28Q3C0U "8HQ2YXHS\M'0+C<4N*4=*
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M.ZPC7/:O%\?,#[UZ9X(O,ND>:RJGJX"I::1Z@.E+2+TI:Y3ZE!1110 4444
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MO!'(TE"\KFI ,KFNGH?--68U:5J%%+UI]">HRBG <TG?% UN)FESF@T@ZT;
M%&:<12$8HV%<3-&:=CBC'% 7&T4X#B@#B@!N:*4"E YHW"XW-%+CFEQS1N V
MBE(YI2*$ W-&:4C%+CB@+C<T4['% '%'D VM#2C_ *9'_O50QP:O:/\ ->1_
M[U3-'3A?C/>="_Y!T7TK6K*T/_D'1?2M6N26Y]?0^ ****DV"BBB@ I#T-+2
M'H: /"_B%_R'#]:Y8'BNI^(7_(;/UKEP/EKM@O=/CL?_ !F)FESB@#-(:K<X
M@S1FE')I<<TT AI*=CYJ5ABCJ/H,S1FE(Q2XXI"&YHIV.* .*/(!M&:<!Q2
M4,!*,TX#FDQ\U&P"49IV.:0CFC8!*,TXBD(Q1L%Q,T9IV.*,<4!<;FBG <4
M<4 -S12@4H'-&X7&YHI<?-2XYHW ;FBE(YI2*$ W-&:4C%+CB@+C<T9IV.*
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M:J8?%*PP]=?0^3FK2'M\M-!Q3C\PS3*%L9"YI.]*!FD[T=1BFD%*.:,<TWN
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MEJI?S>3:NV>@IHF3LKGG_P 0-1\D;0>M>5E]\K-ZUU'C2_\ MEP1G.#7+HN
M*ZZ:L?*XZKSR%I<\8IQ7"YI-ORYK1GG"9HS1CB@#-(0 XHS0!FC'.*-@#/.:
M,\T8YHQSBC8 SFC.:,4$8HV "<T9XQ1BC'&: #/&*,T8XS1CC- !F@'% &:
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MQSBG< SS1FC'.*4C!I;@)G-(32D8H9<"DV-"J<\4A/:E P,TH&Z@GJ-#8&*
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MO(_]ZL_%7M*^:\C_ -ZHF=.&7[P]YT(_\2Z+Z5K5DZ%_R#HOI6M7++<^OH?
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M:* L.S\M Z4WFB@+#P?E-,3J:**=M1]!3UI4ZTW&:.E#8#G&3FD'6E'*TTC
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M*129HSFA !&*7'%(3FC-" 7'% '%)GC%&>* $-:&C\WD?^]6<>E7]'.+R/\
MWJ4]3JPOQGO>A_\ (/B^E:M9.A'_ (ET7TK6KCEN?74/@"BBBI-@HHHH *1O
MNFEI#]TT >&?$(?\3H_6N64?+74?$(_\3L_6N64_+772V/C<?_&8X"F]Z7.*
M2M.IQB@YXI<<TT<4N:$'47'-#C!I,T$YH>HP(P*7'%)G-&:$(7'RT <4F>,4
M9XQ0 H'%(!1F@'%#W 4#FD_BHS29YH8#L<T'@XI,\TF<FAA8<11TI>M-)IV$
M.Z#-(>E)GBC/&*70=A*<!Q3*=GBCH#!13EY.*CS@U(V47-)%*(F/FI=M-![T
M;J&2T[B]\4,N*;GFG,<TXC$HQQ24N>*L$*1\M*!\M-SQ0&XQ6?42$IRBFTH.
M*IL!0.:3'S49I,\TF ['S4CG#8HSS2-\QS05$.CAO2NZ\(ZN5D5"W2N$/2KF
ME7IM;@'..:SDM#JP]5PD?1-C,LL"G/6K5<=X7U47$2*6KL 01Q7-)69]91FI
MP3%HHHJ38**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0
M'FFNP5<FA:BOH4=5NE@M'.<$"O%?%-]]IN3SGFNT\7ZWY#-$&ZUY;>7)GE)S
MWK>G$\+,JZEHB)?6E- Z4&NA*R/!W$7K3L<TT<4N>:$2!'-*129S1G-" ",4
MN.*0G-&:%N N/EI .*,\8HSQ0 H'%(!FC-(#S0]P$-.09-##C-*.!FI"XK+\
MV*3H<4 Y:I?*;;NQ5O8I)LC9<4WI0&W'%(:4M1[#RO&:3'RTH.1BFD]J%L0]
MQ0.* .*3-&:.@ !2@<T@.*,T( Q\U+CFDSSFC-" ".:&%&<T$YI '04N,#--
M)IQ^[22!)B$9YK<T#4C;W2+GC-86>,4Z&0PRA_2@VHS<)7/H#0[Y;B!<MVK<
M'(KR3PKKI+(A;VKU2VE$D"L#U%<LXV9]=A:JG31/124M0=04444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 44AIDCA5)- F[%+4[H00DYQQ7
MD/B?63/.\6[BNP\9:O\ 9K8X;M7DES<FYG+D]:Z:<=#Y_'XB[LB,CG- Y-+G
MBE4<9K4\24KBMP*CQSFG,<TVA,0M%*M(>M4(>HRN:0"@-@8I,TN@V*.:3'-
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MC'.*=[TW/S9H8 1BDI6--IO1 AQ%!'%!/%!/%+H&H8XS1CBC/&*,\4=  #-
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M^2Q,7&;$[4[J*::53S5LXF)CM1BG]\TTGFA@&*3&*<:&H 3%&.]+GBC/RT=
M$Q1BE!^6@'BCH W&:7%*IH!YH ;CM2XH'WJ7/-" ;BEQ0>M*30@&XQ2XI6-&
M>*$ F.]&*7/RT _+0 W%:.D#_3(_]ZL_=@5H:.?],C_WJF:.C#)NHCW?0_\
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MN.\$V6VU1L5WDB[H=OM7-4E>1]/@J=J3N>#>*K7[-=-QC)K _AKOO']E^]W
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MXI67 I@XJ^AS,4GM2@\8H(SS3::0D*#0#2@9%-[TP''CFF@X.:=U%)CFH:!
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M2<]*IA;4>IYS29^:FKTI.]2]QCFZT#BD')I3P,4UL"70>B&>55'K7J?@C23
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M#'-&.<49YHSSFDP#'-!&*,\T$YH8 101@4$T$Y%'0-0QQFC'%&>,49XHZ!J
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M-  101QF@F@GC%'0-0QQFC'%&>,49XQ1T#4 ,T 4 T T=  #FC'.* >:7WI
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M.:,\YH8:@101B@F@G- !CB@CC-*3Q2$\8HZ!J&.,T8XS2@\8H/ Q1T %&12
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MS0@$QSBC%&?FI<\T(!N,4N*">:4FA (1BC'&:4FC/%"W 3'>C%+GY: >* $
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MS-W/H:<%!60E+112+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN@8%-10HXI]<S=SWJ<%%""EHHI&@4444 %%%% !1110 4444 %%%% !1110
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MK%NY]!2IJ"L%%%%2:A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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9%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
